| PERIOD ENDING | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | 31-May-08 | | Total Revenue | 42,174 | 41,260 | 78,301 | 99,136 | | Cost of Revenue | 40,425 | 40,577 | 71,856 | 84,598 | | | Gross Profit | 1,749 | 683 | 6,445 | 14,538 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,108 | 6,597 | 6,910 | 8,115 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,359) | (5,914) | (465) | 6,423 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (4,700) | | Earnings Before Interest And Taxes | (5,094) | (5,021) | 2,067 | 5,525 | | Interest Expense | 629 | 856 | 479 | 1,171 | | Income Before Tax | (5,723) | (5,877) | 1,588 | 4,354 | | Income Tax Expense | (2,138) | (2,131) | 525 | 1,114 | | Minority Interest | 45 | (3) | (195) | (62) | | | | Net Income From Continuing Ops | (3,540) | (3,749) | 868 | 3,178 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,540) | (3,749) | 868 | 3,178 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,540) | ($3,749) | $868 | $3,178 |
|
0.02% Nasdaq 0.00%
Income Statement
